NEW YORK (GenomeWeb News) – Good Start Genetics today said that it has received a clinical lab permit from the New York State Department of Health, enabling the firm to offer its GoodStart Select carrier screening tests to in vitro fertilization and other reproductive health physicians in the sta
NEW YORK (GenomeWeb News) – Natera and Unilabs have struck an agreement under which Unilabs will distribute Natera's non-invasive prenatal screening test, Panorama, in Switzerland and Scandinavia, the companies said today.
NEW YORK (GenomeWeb News) – The University of Manchester today launched a new center for clinical genomics that will develop genetic tests and companion diagnostics and use them along with sequencing tools in the treatment of patients through the UK National Health Service.
NEW YORK (GenomeWeb News) – Myriad Genetics said during its analyst and investor day today that it will launch a new multi-hereditary cancer panel, called myRisk Hereditary Cancer, by the end of this year that will replace its existing BRACAnalysis and other hereditary cancer tests by the summer
NEW YORK (GenomeWeb News) – Foundation Medicine and Memorial Sloan-Kettering Cancer Center today said they are partnering to co-develop a molecular diagnostic tool to match patients who have hematologic cancers with the most appropriate targeted therapies or clinical trials.
NEW YORK (GenomeWeb News) – Myriad Genetics will adopt RainDance Technologies' microdroplet PCR-based target enrichment technology for use in a next-generation sequencing-based hereditary cancer panel test that Myriad is currently developing, the companies said today.
NEW YORK (GenomeWeb News) – Illumina and Kindstar Global, a Chinese diagnostic testing service provider, have signed a strategic collaboration to introduce molecular assays based on Illumina products in Kindstar's laboratories, the companies said today.
NEW YORK (GenomeWeb News) – BGI Health and partners in Turkey have inked a memorandum of understanding to bring genetic testing technologies, including non-invasive fetal trisomy testing, to that country, BGI Health announced this week.